Theophyline ( *** ) - @- Xanthine derivatives- (FDC- List )- (June 1981)
Drug Interaction:
Xanthine derivatives include- Theophylline. Aminophylline, Oxitriphylline,Etophylline
Refer Aminophylline
Cardiac arrhthmias with sympathomimetics (especially with pre-existing cardiac disease).
Tachycardia with pancuronium.
Halothane potentiates cardiac arrhythmias.
Inhibition of metabolism by propranolol and cimetidine.
Erythromycin reduces clearance.
Phenobarb, phenytoin and rifampicin induce metabolism and clearance.
Sulphinpyrazone enhances clearance.
Chronic treatment with ephedrine and theophylline increases adverse effects.
Cal channel blockers inhibit drug metabolism
Quinolone antibiotics inhibit clearance.
Indication:
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
Hydroxyethyltheophylline 231mg + June 1981
Theophylline monohydrate 69mg SR tablet
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
1.Theophylline 400mg SR + 31-03-2009
Montelukast 10mg tablet
For the treatment of patients with bronchial asthma
2.Theophylline anhydrous 100mg + March 1973
Ephedrine HCL 10mg +
Diazepam 1mg +
Prednisolone 1.5mg tablet
Bronchial asthma
Xanthine derivatives include- Theophylline. Aminophylline, Oxitriphylline,Etophylline
Refer Aminophylline
Adverse Reaction:
Cardiac toxicity, neurotoxicity and seizures. Cardiac arrhthmias in pre-existing cardiac disease, tachycardia, anorexia, nausea, tremors, CNS excitation, hyperglycaemia.
Contra-Indications:
Hypersens to xanthine derivatives.
Special precautions:
Not to be chewed or crushed. Do not administer concurrently with other xanthine medications. Caution in patients with severe cardiac disease, hypertension, hyperthyroidism, acute MI injury, CCF and history of peptic ulcer disease. Weigh risks againt benefit in pregnant women. Children.
Dosages/ Overdosage Etc:
Indications:
Bronchial asthma
Dosage: Initial dose- 16 mg/kg/24 hours or 400 mg/24 hours whichever is less. The above doses may be increased in approximately 25% increments at 3 day intervals so long the drug is well tolerated.
Other Information:
For Availability/supplies
Contact -
1.Indian Drug Manufacturers Association (IDMA)
Phone- 022- 24944624/ 24974308
Fax- 022- 24950723
Email- idma@vsnl.com
Website: www.idma-assn.org
2.Bulk Drug Manufacturers Association (India)(BDMA)
Phone - 040-23703910/ 23706718
Fax- 040-23704804
Email- info@bdmai.org
Website: www.info@bdmai.org
Patient Information:
Refer aminophylline
Pharmacology/ Pharmacokinetics:
Refer aminophylline
Interaction with Food:
Refer aminophyllines
Pregnancy and lactation:
Refer aminophyllines